ATE502637T1 - Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum - Google Patents
Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikumInfo
- Publication number
- ATE502637T1 ATE502637T1 AT06704250T AT06704250T ATE502637T1 AT E502637 T1 ATE502637 T1 AT E502637T1 AT 06704250 T AT06704250 T AT 06704250T AT 06704250 T AT06704250 T AT 06704250T AT E502637 T1 ATE502637 T1 AT E502637T1
- Authority
- AT
- Austria
- Prior art keywords
- anticholinergic
- prevention
- treatment
- heart failure
- medications
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title abstract 3
- 230000001078 anti-cholinergic effect Effects 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64801205P | 2005-01-28 | 2005-01-28 | |
| PCT/EP2006/050408 WO2006079625A2 (en) | 2005-01-28 | 2006-01-24 | Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE502637T1 true ATE502637T1 (de) | 2011-04-15 |
Family
ID=36129748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06704250T ATE502637T1 (de) | 2005-01-28 | 2006-01-24 | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7923455B2 (enExample) |
| EP (1) | EP1843764B1 (enExample) |
| JP (1) | JP2008528547A (enExample) |
| AT (1) | ATE502637T1 (enExample) |
| CA (1) | CA2594693A1 (enExample) |
| DE (1) | DE602006020838D1 (enExample) |
| ES (1) | ES2362365T3 (enExample) |
| WO (1) | WO2006079625A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060287347A1 (en) * | 2005-06-21 | 2006-12-21 | Aberg A K G | Methods for treating smooth muscle disorders using trospium |
| US20070004766A1 (en) * | 2005-07-01 | 2007-01-04 | Aberg A K G | Methods for relaxation of smooth muscle contractions using Trospium |
| WO2007017436A2 (en) * | 2005-08-08 | 2007-02-15 | Boehringer Ingelheim International Gmbh | Method for the protection against the risk of cardiac disorders comprising administration of tiotropium salts |
| JO3510B1 (ar) | 2011-03-04 | 2020-07-05 | Heptares Therapeutics Ltd | استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب |
| CZ2014188A3 (cs) | 2014-03-26 | 2015-10-07 | Zentiva, K.S. | Nové formy aclidinium chloridu a způsob jejich přípravy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002096422A2 (en) * | 2001-05-25 | 2002-12-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways |
| KR20060011783A (ko) * | 2002-06-12 | 2006-02-03 | 에피제네시스 파마슈티칼스 아이엔씨 | 데하이드로에피안드로스테론 스테로이드 및항-무스카린제와 더불어 호흡기 및 폐 질환을 치료하기위한 조성물, 제제 및 키트 |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| US20050239778A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim International Gmbh | Novel medicament combinations for the treatment of respiratory diseases |
| EA013157B1 (ru) * | 2004-04-22 | 2010-02-26 | Бёрингер Ингельхайм Интернациональ Гмбх | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей |
-
2006
- 2006-01-13 US US11/332,646 patent/US7923455B2/en active Active
- 2006-01-24 ES ES06704250T patent/ES2362365T3/es active Active
- 2006-01-24 JP JP2007552632A patent/JP2008528547A/ja active Pending
- 2006-01-24 DE DE602006020838T patent/DE602006020838D1/de active Active
- 2006-01-24 AT AT06704250T patent/ATE502637T1/de active
- 2006-01-24 EP EP06704250A patent/EP1843764B1/en active Active
- 2006-01-24 CA CA002594693A patent/CA2594693A1/en not_active Abandoned
- 2006-01-24 WO PCT/EP2006/050408 patent/WO2006079625A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2594693A1 (en) | 2006-08-03 |
| EP1843764B1 (en) | 2011-03-23 |
| WO2006079625A3 (en) | 2007-07-26 |
| US20060173038A1 (en) | 2006-08-03 |
| EP1843764A2 (en) | 2007-10-17 |
| US7923455B2 (en) | 2011-04-12 |
| JP2008528547A (ja) | 2008-07-31 |
| DE602006020838D1 (de) | 2011-05-05 |
| WO2006079625A2 (en) | 2006-08-03 |
| ES2362365T3 (es) | 2011-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
| CY1111478T1 (el) | Ενδειξη δοσολογιας προγεστερονης στην αντιμετωπιση τραυματικης εγκεφαλικης βλαβης | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| WO2004006842A3 (en) | Combinations of drugs for the treatment of neoplasms | |
| ATE453642T1 (de) | Substituierte phenylaminopyrimidine | |
| PH12021553102A1 (en) | Methods of treating fabry disease in patients having renal impairment | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| WO2004006849A3 (en) | Combinations of drugs for the treatment of neoplasms | |
| ATE353650T1 (de) | Kombinationstherapie zur behandlung von krebs | |
| ATE499933T1 (de) | Verwendung von betain zur behandlung von claudicatio intermittens | |
| ATE502637T1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
| ATE487480T1 (de) | Perhexilin zur behandlung von chronischer herzinsuffizienz | |
| ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
| WO2006015970A3 (en) | Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic | |
| EP4245366A3 (en) | Migalastat for treating fabry patients having renal impairment | |
| DE60330857D1 (de) | 5-ht4 antagonisten zur behandlung von herzversagen | |
| WO2005081972A3 (en) | Maleiimide anti-tumor phosphatase inhibitors | |
| ATE407925T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
| EA202090416A1 (ru) | Способы лечения симптомов гастропареза с использованием велусетрага | |
| ATE451145T1 (de) | Behandlung von krankheiten | |
| EA200702274A1 (ru) | Твёрдые кристаллические и аморфные формы (-)-галофената и способ их получения, фармацевтическая композиция на их основе и способ лечения | |
| EA200970292A1 (ru) | Производные 5-тиоксилопиранозы и их применение в терапии | |
| ATE402147T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
| TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors | |
| EA200970293A1 (ru) | Новые производные 5-тиоксилопиранозы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1843764 Country of ref document: EP |